A similar pattern is also seen with SHH inhibitors, as one study has shown that treating EGFR inhibitor-resistant HNSCC cells with the SHH inhibitor IPI-926 reduces tumor growth and blocks tumor recurrence in patient-derived HNSCC xenografts [179]. The gene discussed is SHH; the disease is neoplasm.